From: Respiratory challenges and ventilatory management in different types of acute brain-injured patients
Respiratory management (references) | Normal lung | Normal lung | ARDS | ARDS |
---|---|---|---|---|
Normal ICP | High ICP | Normal ICP | High ICP | |
7–9 ml/kg PBW | 7–9 ml/kg PBW | 6–8 ml/kg PBW | 6–8 ml/kg PBW | |
5 cmH2O | 5 cmH2O. If higher PEEP, surveillance of ICP/CPP/multimodal brain monitoring | At least 5 cmH2O, higher PEEP in more severe ARDS, titration based on plateau pressure, driving pressure, oxygenation and hemodynamic response to higher PEEP | At least 5 cmH2O, higher PEEP in more severe ARDS, titration based on plateau pressure, driving pressure, oxygenation and hemodynamic response to higher PEEP ICP/CPP/multimodal brain monitoring | |
Avoid hyperoxemia (PaO2 > 200) | PaO2 80–200 | PaO2 80–120, depending of ARDS severity | PaO2 80–200 | |
PaCO2 target (mmHg) [38] | PaCO2 35–45 | PaCO2 32–38 | Permissive hypercapnia (< 60), depending on pH (> 7, 25) | Permissive hypercapnia contraindicated. Adjunctive therapy earlier ICP/CPP/multimodal brain monitoring |
Prone position [52] | Not recommended | Not recommended | PaO2/FIO2 < 150 mmHg with PEEP ≥ 5 cmH2O | PaO2/FIO2 < 150 mmHg Case-by-case basis ICP/CPP/multimodal brain monitoring |
Lung recruitment [53] | Systematic use, not recommended | Systematic use, not recommended | Systematic use, not recommended | Systematic use, not recommended |
Not recommended unless specific indication | Avoid positive fluid balance and target euvolemia for CPP management Avoid hypotonic fluids | Yes | Avoid positive fluid balance and target euvolemia for CPP management Avoid hypotonic fluids ICP/CPP/multimodal brain monitoring | |
No indication except for specific indication | Higher mortality in TBI with high dose of methylprednisolone | Dexamethasone may be indicated | If TBI severity is the main problem steroids may be avoided. Steroids may be beneficial if ARDS is the dominant problem |